Fentanyl Patch, Extended Release
Product Images NDC 3215-7707

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Fentanyl (NDC 3215-7707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aveva Drug Delivery Systems Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A To D (Figure A D)

Figure A To D (Figure A D)
Illustrations showing appropriate application sites for FENTANYL transdermal patches on the body. Figures depict patches placed on the upper chest, upper back, side torso, and side of the chest below the armpit, indicating recommended skin areas for patch placement.*
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
An instructional illustration labeled Figure E showing a person applying a patch to the left side of the chest, indicating the application site for a transdermal patch, such as a fentanyl extended-release patch.*
FDA Label Image

Figure F (Figure F)

Figure F (Figure F)
An instructional diagram labeled Figure F, showing hands using scissors to cut open a packet or pouch, likely related to the preparation or use of a fentanyl transdermal patch.*
FDA Label Image

Figure G (Figure G)

Figure G (Figure G)
An instructional illustration labeled Figure G showing two hands holding and peeling apart a rectangular patch, likely demonstrating the application or removal of a transdermal patch.*
FDA Label Image

Figure H (Figure H)

Figure H (Figure H)
An illustration showing a person applying a fentanyl transdermal patch to the upper chest area below the clavicle. The figure is labeled 'Figure H' and depicts the proper placement of the extended-release patch on the skin.*
FDA Label Image

Figure I To J (Figure I J)

Figure I To J (Figure I J)
An instructional illustration showing two figures. Figure I depicts hands peeling off a protective backing from a transdermal patch. Figure J shows a hand placing a used patch into a disposal container. Both figures are part of usage or disposal instructions for a transdermal patch product.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A pharmacokinetic curve showing fentanyl concentration (ng/mL) over time (hours) for two dosing regimens of a 100 mcg/hr transdermal fentanyl system. The graph compares concentration profiles for a single patch (1x) versus four patches (4x) applied, with error bars indicating variability and time points extending to approximately 340 hours.*
FDA Label Image

Carton 12 Mcg (Image001)

Carton 12 Mcg (Image001)
Fentanyl Transdermal System 12 mcg/h extended-release patch packaging label for a single patch. The label includes usage warnings, dosage information, and the statement that each system contains 1.38 mg fentanyl. The labeler is Aveva Drug Delivery Systems Inc. The package features serialization area and barcode, with a predominantly white background and yellow highlight on the strength.*
FDA Label Image

Carton 25 Mcg (Image002)

Carton 25 Mcg (Image002)
Packaging label for Fentanyl Transdermal System 25 mcg/h by Aveva Drug Delivery Systems Inc. The label indicates a transdermal patch delivering 25 mcg/h of fentanyl over 72 hours, containing 2.76 mg fentanyl per patch. The label includes warnings to avoid use if the seal is broken, and to keep out of reach of children, along with serialization and barcode areas.*
FDA Label Image

Carton 37.5 Mcg (Image003)

Carton 37.5 Mcg (Image003)
Packaging label for Fentanyl Transdermal System 37.5 mcg/h patch by Aveva Drug Delivery Systems Inc. This extended-release transdermal patch delivers 37.5 micrograms per hour of fentanyl, indicated on the label. The carton includes usage cautions, a barcode, serialization area, and manufacturer information.*
FDA Label Image

Carton 50 Mcg (Image004)

Carton 50 Mcg (Image004)
Box packaging for Fentanyl Transdermal System 50 mcg/h, an extended-release patch for transdermal use by Aveva Drug Delivery Systems Inc. The label includes warnings about respiratory risks and opioid use, dosage information, and a barcode. The product is prescription only and the box design features purple and red accents.*
FDA Label Image

Carton 62.5 Mcg (Image005)

Carton 62.5 Mcg (Image005)
The packaging label for Fentanyl Transdermal System 62.5 mcg/h patch, an extended release transdermal dosage form by Aveva Drug Delivery Systems Inc. The box includes warnings about respiratory risks and instructions not to use if the seal is broken. It also states the patch delivers 62.5 mcg/h of fentanyl over 72 hours, containing 6.90 mg fentanyl per system.*
FDA Label Image

Carton 75 Mcg (Image006)

Carton 75 Mcg (Image006)
Packaging label for Fentanyl Transdermal System 75 mcg/h patch, extended-release, manufactured by Aveva Drug Delivery Systems Inc. The label includes warnings about breathing risks, usage instructions, and serialization area. The label states a 72-hour delivery of 75 mcg/h fentanyl with each patch containing 8.28 mg fentanyl. It features barcoding, regulatory marks, and safety information.*
FDA Label Image

Carton 87.5 Mcg (Image007)

Carton 87.5 Mcg (Image007)
Packaging label for Fentanyl Transdermal System 87.5 mcg/h, an extended-release patch for transdermal use. The label displays dosage strength, warnings about respiratory risk, and usage duration of 72 hours per patch. Manufactured by Aveva Drug Delivery Systems Inc., the carton includes serialization information, a barcode, and the Rx Only symbol.*
FDA Label Image

Carton 100 Mcg (Image008)

Carton 100 Mcg (Image008)
Packaging label for Fentanyl Transdermal System 100 mcg/h extended release patch. The label indicates a box containing five systems, each delivering 100 mcg per hour of fentanyl transdermally. The label includes safety warnings, a barcode, and manufacturer information for Aveva Drug Delivery Systems Inc.*
FDA Label Image

Patch (Patch)

Patch (Patch)
An illustration diagram of a transdermal patch showing its three layers: release liner, drug containing layer, and backing layer. The diagram depicts the release liner being peeled back to expose the drug containing layer, with the backing layer on the opposite side.*
FDA Label Image

Patch (Patch2)

Patch (Patch2)
Illustration showing the layered structure of a FENTANYL transdermal patch, including the release liner, drug-containing layer, and backing layer as labeled components.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of fentanyl, showing the molecular arrangement of its atoms and bonds in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.